Clinilabs Drug Development Corporation
Clinilabs Drug Development Corporation
Eatontown, New Jersey, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Skin Abnormalities, Skin and Connective Tissue Diseases, arterial calcification of infancy, autosomal recessive inherited pseudoxanthoma elasticum, cardiovascular disorder, connective tissue disorder, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary skin disorder, hypophosphatemic rickets, autosomal recessive, 2, skin disorder, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-08-28 | NCT06462547 | |
| Clinical Trials of Multivalent Opioid Vaccine Components | Chemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-23 | NCT04458545 | |
| Continuation Protocol for Obstructive Sleep Apnea (OSA) | Apnea, Dyssomnias, Respiration Disorders, Sleep Disorders, Intrinsic, nervous system disorder, obstructive sleep apnea syndrome, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Enrolling by invitation | Phase 3 | 2025-05-13 | NCT06566820 |